Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$576K Buy
5,195
+266
+5% +$27.2K 0.49% 50
2022
Q3
$425K Sell
4,929
-499
-9% -$44.5K 0.4% 60
2022
Q2
$495K Hold
5,428
0.43% 54
2022
Q1
$445K Buy
5,428
+178
+3% +$14K 0.36% 62
2021
Q4
$402K Buy
+5,250
New +$418K 0.3% 73

Other funds holding MRK

Resolute Financial's MRK Position: Q4 2022 in Review

Resolute Financial increased its Merck (MRK) stake by 5.4% in Q4 2022, buying an estimated $27.2K and bringing the position to 5,195 shares worth $576K. The position accounts for 0.49% of the portfolio, ranked #50.

Resolute Financial first reported a position in MRK in Q4 2021 and has held it in 5 quarters since. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Resolute Financial held 5,195 shares of Merck worth $576K as of Q4 2022.
  • Resolute Financial bought 266 Merck shares in Q4 2022, an estimated $27.2K.
  • Merck made up 0.49% of Resolute Financial's portfolio in Q4 2022, its #50 holding.
  • Resolute Financial first reported a position in Merck in Q4 2021 and has held it in 5 quarters since.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Resolute Financial's 13F filing for Q4 2022, filed 13 Feb 2023.